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Cases of sporotrichosis in humans and animals without satisfactory clinical response have increased, 
a warning sign of strains resistant to conventional antifungal agents. The urgent search for alternative 
therapies was an incentive for research on medicinal plants with anti-Sporothrix spp. properties. A 
bibliographic survey was performed based on scientific papers about in vitro and in vivo antifungal activity 
of essential oils and extracts of plants in differents solvents against the fungal of the Sporothrix schenckii 
complex. The study methodology consisted of a literature review in Google Scholar, Science Direct, 
Pubmed, Bireme and Springer link with papers from 1986 to 2015. We found 141 species of plants that 
were investigated, of which 100 species were concentrated in 39 botanical families that had confirmed 
anti-Sporothrix activity. Combretaceae, Asteraceae and Lamiaceae represented the botanical families with 
the greatest number of plants species with antifungal potential, using different methodologies. However, 
there are few studies with medicinal plants in experimental infection in animals that prove their activity 
in the treatment of sporotrichosis. It reinforces the need for further research related to standardization 
of in vitro methodologies and in vivo studies related to safety and to toxicity potential of these plants 
with anti-Sporothrix spp. activity.
Uniterms: Sporothrix schenckii complex. Antifungals. Combretaceae/pharmacognosy. Asteraceae/
pharmacognosy. Lamiaceae/pharmacognosy. Medicinal plants/antifungal activity.
Casos de esporotricose em humanos e animais sem resposta clínica satisfatória têm aumentado, sinal 
de alarme para o surgimento de cepas resistentes aos antifúngicos convencionais. A urgente busca por 
alternativas terapêuticas tem incentivado as pesquisas em plantas medicinais com atividade anti-Sporothrix 
spp. Um levantamento bibliográfico foi realizado com base em artigos científicos sobre a atividade 
antifúngica in vitro e in vivo de óleos essenciais e extratos de plantas preparados em diferentes solventes 
contra o complexo Sporothrix schenckii. A metodologia do estudo consistiu em uma revisão bibliográfica 
em Google Scholar, Science Direct, Pubmed, Bireme e Springer link com artigos desde 1986 até 2015. 
Foram encontradas 141 espécies de plantas já investigadas, das quais 100 espécies concentradas em 39 
famílias botânicas apresentaram atividade anti-Sporothrix spp. confirmada. Combretaceae, Asteraceae 
e Lamiaceae representaram as famílias botânicas com maior número de espécies vegetais com potencial 
antifúngico, empregando diferentes metodologias. Entretanto, há poucos estudos com plantas medicinais 
em infecção experimental animal comprovando sua atividade no tratamento da esporotricose. Reforça-
se a necessidade de mais pesquisas relacionadas à padronização de metodologias in vitro e a estudos 
in vivo relacionados à segurança e potencial tóxico dessas plantas com atividade anti-Sporothrix spp.
Unitermos: Sporothrix schenckii. Antifúngicos. Combretaceae/farmacognosia. Asteraceae/farmacognosia. 
Lamiaceae/farmacognosia. Plantas medicinais/atividade antifúngica.
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INTRODUCTION
Among the diseases with zoonotic potential, 
sporotrichosis is recognized as an emerging mycosis with 
worldwide occurrence that tends to increase exponentially 
in the number of cases in domestic animals and humans 
and is considered a neglected epidemic in the state of Rio 
de Janeiro, Brazil (Schubach, Barros, Wanke, 2008; Barros 
et al., 2010; Silva et al., 2012; Rodrigues et al., 2013). 
This disease is the most common subcutaneous mycosis 
in the Americas, especially in Brazil, Mexico, Colombia 
and Peru, and also occurs in South Africa, India and Japan 
(Carrada-Bravo, Olvera-Macías, 2013). The sources of 
environmental fungus infection include soil, decomposed 
vegetation, tree stems, and other elements. The infection 
may also occur through bites and scratches of cats that may 
carry Sporothrix spp. conidia and, through inoculation, 
transmit the fungal agent into the dermis (Larsson, 2011; 
Romeo, Criseo, 2013). Although the treatment with 
antifungal drugs is effective, in vitro studies acknowleded 
the emergence of strains of Sporothrix spp. resistant to 
antifungals (Meinerz et al., 2007; Marimon et al., 2008; 
Rodrigues et al., 2013; Stopiglia et al., 2014).
There is a continuing and urgent need to discover 
new antifungal compounds and to understand their 
mechanisms of action (Kontoyiannis, Lewis, 2002; Cleff 
et al., 2008; Gaitán et al. 2011). It is known that the use of 
plants and derivatives for medicinal purposes is an ancient 
practice used worldwide, primarily in Eastern cultures, and 
is utilized by up to 80% of the population of developing 
countries and has been increasingly used in the West, 
according to data from the World Health Organization in 
the 1990’s (Veiga Jr., Pinto, 2005).
Faced with resistant cases of sporotrichosis, the 
search for alternative therapies in their treatment has 
increasingly been conducted by several international 
researchers, whose papers reveal the potential anti-
Sporothrix spp. of certain medicinal plants (Rojas et al., 
2003; Masoko, Picard, Eloff, 2007; Cleff et al., 2008; 
Suleiman et al., 2009; Johann et al., 2011; Joshi et al., 
2011; Stopiglia et al., 2011). However, there is a lack of 
standardization of tests with medicinal plants and this 
makes the comparison of antifungal activity of the plants 
difficult. Thus, this review aimed for a new approach of 
sporotrichosis and grouped the studies in the medicinal 
plants with anti-Sporothrix spp. activity according to the 
methodology for antifungal evaluation. A bibliographic 
survey was performed based on scientific papers 
researched in Google Scholar, Science Direct, Pubmed, 
Bireme and Springer link and papers from 1986 to 2015 
were evaluated.
SPOROTRICHOSIS AND ITS CONVENTIO-
NAL THERAPY
Chronic or subacute, the clinical manifestations 
of sporotrichosis occur in dependence of the host 
immune status, commonly resulting in limited damage 
to the dermis, with or without involvement of the 
lymphatic system in humans and animals, which can 
produce subcutaneous nodules, and may also produce 
manifestations in the respiratory system, such as dyspnea, 
nasal discharge and sneezing (Schubach, Barros, Wanke, 
2008; Barros et al., 2010; Madrid et al., 2012).
The conventional therapy for sporotrichosis 
includes the use of antifungal agents such as potassium 
iodide, itraconazole, ketoconazole, amphotericin B and 
terbinafine, among others, as well as the adoption of local 
thermal therapy and the surgical excision of the lesion 
(Meinerz et al., 2008; Gremião et al., 2009; Honse et al., 
2010; Pereira et al., 2011; Gremião et al., 2011; Reis et al., 
2012). The preferred antifungal therapy for cat and dogs 
with sporotrichosis has been itraconazole administered 
daily orally at the dose of 10 to 40 mg kg-1 for a minimum 
period of three months and up to one year with no apparent 
adverse effects (Madrid et al., 2010; Larsson, 2011; Rossi 
et al., 2013). However, poor clinical response has been 
observed in cats with sporotrichosis (Gremião et al., 2011).
The daily use of potassium iodide in capsules at dose 
of 2.5 to 20 mg kg-1 has provided clinical cure, although 
side effects may occur, as appetite loss and clinical signs 
of hepatotoxicity (Reis et al., 2012). The association of 
subcutaneous amphotericin B with oral itraconazole is 
also an alternative in cats with sporotrichosis refractory 
to itraconazole (Gremião et al., 2011). Furthermore, the 
association of itraconazole with (1-3) β-glucan promoted 
the case resolution after four weekly applications of 
glucan in a canine with refractory sporotrichosis to 
itraconazole by Sporothrix brasiliensis and it may be 
considered a promising alternative in cases of resistance 
to conventional therapy (Guterres et al., 2014). In 
humans, the recommended the daily dosage of 100 up to 
400 mg kg-1 of itraconazole has been succesfully used in 
a study with 645 patients, which the recovery rate was 
94.6% (Barros et al., 2010). 
Experimental models in rats showed better activity 
of terbinafine (250 mg kg-1) compared to itraconazole 
(100 mg kg-1) in treatment of systemic sporotrichosis 
(Meinerz et al., 2008), but in the cutaneous sporotrichosis, 
terbinafine (20 e 30 mg kg-1) has shown little efficacy 
while itraconazole (10 mg kg-1) showed good results 
(Antunes et al., 2009). In human isolates of S. schenckii, 
S. brasiliensis and S. globosa, terbinafine had better in 
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vitro antifungal activity, followed by ketoconazole and 
fluconazole (Stopiglia et al., 2014).
The therapeutic protocol adopted must be associated 
with clinical monitoring of the patient, especially in felines 
because they are sensitive to many medications (Nobre 
et al., 2002; Madrid et al., 2012). Toxic effects has been 
cited in cats and dogs treated with azoles, such as anorexia, 
emesis and hepatotoxic signs, as well as lethal cases in cats 
treated with saturated sodium solutions or 20% potassium 
iodide (Larsson, 2011).
The difficulties in obtaining therapeutical success 
can be associated with treatment time and the high cost of 
drugs that has been discouraging to the animals´ owners, 
who often abandon the therapy. These factors coupled 
with the indiscriminate use of antifungal drugs contributed 
to the problem of antifungal resistance (Schubach et al., 
2004; Marimon et al., 2008; Rodrigues et al., 2013). 
Unfortunately, in vitro studies showed the emergence 
of Sporothrix spp. resistant to antifungals, including 
itraconazole, which is used as the preferred therapy in 
sporotrichosis (Marimon et al., 2008; Rodrigues et al., 
2013; Stopiglia et al., 2014).
The difficulties observed in the therapeutical cure in 
human and animals show that the current situation calls for 
new therapeutic alternatives and/or new complements to 
conventional antifungal therapy. It is know that medicinal 
plants present antimicrobial properties which have been 
increasingly reported in international studies and it is 
expected that plant extracts have different target sites 
than used by currently available antimicrobials in being 
effective against drug-resistant microbial pathogens 
(Gibbons, 2003), including resistant strains of Sporothrix 
spp.
Currently, the agent of sporotrichosis has been 
reclassified and related to several species of Sporothrix 
schenckii complex, such as S. brasiliensis, S. globosa, S. 
mexicana, S. albicans, S. inflata, S. schenckii var. luriei 
and S. schenckii var. schenckii; which are identified only 
by molecular biology techniques (Marimon et al., 2007). 
However, the studies on medicinal plants found in this 
review were only conducted with isolates of S. schenckii 
because this agent was, at the time, the only species 
identified in cases of sporotrichosis, since the genre had 
not yet been classified as Sporothrix schenckii complex.
PLANTS WITH ANTI-SPOROTHRIX SPP. PO-
TENTIAL
Among the first reports of the search of plants with 
possible antifungal activity against S. schenckii, Minami 
and Oliveira (1986) studied alcoholic extract at 30% of 
Bidens pilosa (Compositae), a plant distributed in America, 
Asia and Africa, and they found no inhibitory antifungal 
activity. Fortunately, studies in the years following 
detected satisfactory in vitro activity of other plant 
species tested in different extracts types, concentrations 
and methodologies (Sinha, Gulati, 1990; Apisariyakul, 
Vanittanakom, Buddhasukh, 1995; Verástegui et al., 1996; 
Saikia et al., 2001; Rojas et al., 2003; Masoko, Picard, 
Eloff, 2005; Luqman et al., 2007; Damián-Badillo et al., 
2008).
According to the queried data, 141 species of plants 
have been subjected to in vitro tests against S. schenckii, 
and anti-Sporothrix spp. activity was conferred in 100 
species belonging to 39 botanical families, in which 
were highlighted the families of Combretaceae (31% - 
31/100) (Masoko, Picard, Eloff, 2005; 2007; Suleiman 
et al., 2009), Asteraceae (11% - 11/100) (Rojas et al., 
2003; Damián-Badillo et al., 2008; Salomão et al., 2008; 
Stopiglia et al., 2011) and Lamiaceae (7% - 07/100) 
(Sinha, Gulati, 1990; Luqman et al., 2007; Fernández, 
2005; Cleff et al., 2008; Couto et al., 2015), which have 
the largest number of species with confirmed activity of 
interest. From the in vitro studies revised, a total of 233 
extract products showed anti-Sporothrix spp. activity. 
The botanical information according to the consulted 
references is described in Table I.
IN VITRO SUSCEPTIBILITY TESTS
In the studies reviewed, the methodology utilized 
for research on plants were agar diffusion (Apisariyakul et 
al., 1995; Saikia et al., 2001; Rojas et al., 2003; Luqman 
et al., 2007; Damián-Badillo et al., 2008; Verástegui et 
al., 2008; Fatima et al., 2009; Márquez, 2010; Joshi et 
al., 2011), broth microdilution technique (Sinha, Gulati, 
1990; Verástegui et al., 1996; Johann et al., 2007; Luqman 
et al., 2007; Cleff et al., 2008; Fatima et al., 2009; Johann 
et al., 2009, 2011; Joshi et al., 2011), bioautographic 
assay (Betina, 1973; Johann et al., 2007; 2011), serial 
microdilution at 24 and 48 hours (Masoko, Picard, Eloff, 
2005; 2007; Suleiman et al., 2009) and agar cup method 
(Salomão et al., 2008).
In the various methodologies utilized in the 
references, variation was observed in the values of 
concentration tested in extracts, making it difficult to 
compare the results and, thus, the designation of those 
plants with high, medium and low anti-Sporothrix spp. 
activity was not performed. According to Fennel et al. 
(2004), the lack of standardized methods for antimicrobial 
tests with natural products results in variations of 
minimum inhibitory concentration values. In addition, 
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TABLE I - Medicinal plants with confirmed anti-Sporothrix spp. activity and their taxonomical and anatomical identifications, 
extract types and the country where the study was conducted by the consulted references
Botanical 
Family Plant Species Plant Parts Extract Country Reference
Agavaceae Agave lecheguilla Root E Mexico Verástegui et al.,1996; 
2008
Leaves E Mexico Verastegui et al., 2008
Agavaceae Agave lophantha Leaves E Mexico Verastegui et al., 2008
Agavaceae Agave picta Leaves E Mexico Verastegui et al., 2008
Agavaceae Agave scabra Leaves E Mexico Verastegui et al., 2008
Anacardiaceae Schinus terebinthifolius Leaves, Stems Di, E, EA, He Brazil Johann et al., 2007
Anacardiaceae Loxostylis alata Leaves Ac, Aq, Bu, Ch, 
CT Di, He, Ch, M
South Africa, 
Nigeria
Suleiman et al., 2009; 
Suleiman, Naidoo, Eloff, 
2012
Anacardiaceae Protorhus longifolia Leaves Ac, Di, He, M South Africa, 
Nigeria
Suleiman et al., 2009
Apiaceae Cuminum cyminum Seed Aq, EO, Ha, M India Chaudhary, Husain, Ali, 
2014
Araucariaceae Araucaria spp. Resin E Brazil Salomão et al., 2008
Asteraceae Artemisia ludoviciana Leaves, Root, 
Flowers
Aq, EA, MC Mexico Damián-Badillo et al., 
2008
Asteraceae Heliopsis longipes Leaves, Root, 
Flowers
Aq, EA, MC Mexico Damián-Badillo et al., 
2008
Asteraceae Tagetes lucida Leaves, Root, 
Flowers
Aq, EA, MC Mexico Damián-Badillo et al., 
2008
Asteraceae Baccharis dracunculifolia Resin E Brazil Salomão et al., 2008
Asteraceae Ophryosporus peruvianus Leaves, Stems E Peru Rojas et al., 2003
Asteraceae Senecio culcitioides Aerial Parts E Peru Rojas et al., 2003
Asteraceae Pterocaulon balansae Aerial Parts M Brazil Stopiglia et al., 2011
Asteraceae Pterocaulon cordobense Aerial Parts M Brazil Stopiglia et al., 2011
Asteraceae Pterocaulon lanatum Aerial Parts M Brazil Stopiglia et al., 2011
Asteraceae Pterocaulon lorentzii Aerial Parts M Brazil Stopiglia et al., 2011
Asteraceae Pterocaulon polystachyum Aerial Parts M Brazil Stopiglia et al., 2011
Burseraceae Commiphora harveyi Leaves Ac, Di, He, M South Africa, 
Nigeria
Suleiman et al., 2009
Caesalpiniaceae Senna alata Leaves E Guatemala Fernández, 2005
Caesalpiniaceae Hymenaea courbaril Leaves E Guatemala Sánchez, 2009
Campanulaceae Lobelia pyramidalis Aerial Parts EO Índia Joshi et al., 2011
Chloranthaceae Hedyosmum mexicanum Leaves E Guatemala Castellanos, 2007
Clusiaseae Hypericum uliginosum Grass E Guatemala Fernández, 2005
Combretaceae Terminalia brachystemma Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2005
Combretaceae Terminalia gazensis Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2005
Combretaceae Terminalia mollis Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2005
Combretaceae Terminalia prunioides Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2005
Combretaceae Terminalia sambesiaca Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2005
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Botanical 
Family Plant Species Plant Parts Extract Country Reference
Combretaceae Terminalia sericea Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2005; 2010b; Masoko et 
al., 2010a; 




Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007; 2010b; Masoko et 
al., 2010a 
Combretaceae Combretum apiculatum Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum bracteosum Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum caffrum Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum celastroides 
spp. celastroides
Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum celastroides 
spp. orientale
Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum collinum spp. 
suluense
Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum collinum spp. 
taborense
Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007




Leaves Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum hereroense Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum imberbe Leaves Di South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum kraussii Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum microphyllum Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum moggii Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007




Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum nelsonii Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007; 2010b; Masoko et 
al., 2010a;
Combretaceae Combretum padoides Leaves Ac, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum paniculatum Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
TABLE I - Medicinal plants with confirmed anti-Sporothrix spp. activity and their taxonomical and anatomical identifications, 
extract types and the country where the study was conducted by the consulted references (cont.)
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Botanical 
Family Plant Species Plant Parts Extract Country Reference
Combretaceae Combretum petrophilum Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum woodii Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum zeyheri Leaves Ac, Di, He, M South Africa Masoko, Picard, Eloff, 
2007
Combretaceae Combretum vendae Leaves Ac, Di, He, M South Africa, 
Nigeria
Suleiman et al., 2009
Compositae Baccharis glutinosa Leaves E Mexico Verástegui et al.,1996
Cornaceae Curtisia dentata Leaves, Stems Ac, Di, He, M South Africa Shai et al., 2008
Euphorbiaceae Croton ruizianus Leaves, Stems E Peru Rojas et al., 2003
Fabaceae Glycyrrhiza glabra Root E, EA Índia Fatima et al., 2009
Fabaceae Diphysa robinioides Leaves E Guatemala Sánchez, 2009
Geraniaceae Perlagonium graveolens - EO Índia Singh et al., 2012
Hydrophyllaceae Wigandia urens Leaves, Stems E Peru Rojas et al., 2003
Kirkiaceae Kirkia wilmsii Leaves Ac, Di, He, M South Africa, 
Nigeria
Suleiman et al., 2009
Labiateae Satureja macrostema Leaves, Root Aq, EA, MC Mexico Damián-Badillo et al., 
2008
Lamiaceae Origanum vulgare Aerial Parts EO Brazil Cleff, 2008; Couto et al., 
2015
Lamiaceae Salvia lavanduloides Leaves, Flowers E Guatemala Fernández, 2005
Lamiaceae Rosmarinus officinalis Leaves EO Índia Luqman et al., 2007
Lamiaceae Ocimum basilicum - EO Índia Sinha, Gulati, 1990
Lamiaceae Ocimum canum 
(americanum)
- EO Índia Sinha, Gulati, 1990
Lamiaceae Ocimum gratissimum - EO Índia Sinha, Gulati, 1990
Lamiaceae Ocimum sanctum - EO Índia Sinha, Gulati, 1990
Lauraceae Cinnamomum zeylanicum Cortex He Mexico Márquez, 2010
Liliaceae Agapanthus africanus Root E India Singh et al., 2008
Meliaceae Khaya anthotheca Leaves Ac, Di, He, M South Africa, 
Nigeria
Suleiman et al., 2009
Moraceae Dorstenia contrajerva Root E Guatemala Castellanos, 2007
Myristicaceae Iryanthera lancifolia Stems E Peru Rojas et al., 2003
Myrtaceae Eucalyptus camaldulensis Leaves M Mexico Márquez, 2010
Myrtaceae Eucalyptus citriodora - EO India Akhtar et al., 2014
Myrtaceae Psidium guajava Leaves Ac, He Mexico Márquez, 2010
Myrtaceae Syzygium aromaticum Sprouts He Mexico Márquez, 2010
Myrtaceae Psidium acutangulum Leaves E Peru Wen et al., 2011
Ochnaceae Ochna natalitia Leaves Ac, Di, He, M South Africa, 
Nigeria
Suleiman et al., 2009
Onagraceae Oenothera multicaulis Aerial Parts, Root E Peru Rojas et al., 2003
Piperaceae Piper abutiloides Aerial Parts Ha Brazil Johann et al., 2009
Poaceae Cymbopogon flexuosus - EO Índia Saikia et al., 2001
Poaceae Cymbopogon martini - EO Índia Saikia et al., 2001
Poaceae Cymbopogon winterianus - EO Índia Saikia et al., 2001
TABLE I - Medicinal plants with confirmed anti-Sporothrix spp. activity and their taxonomical and anatomical identifications, 
extract types and the country where the study was conducted by the consulted references (cont.)
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Botanical 
Family Plant Species Plant Parts Extract Country Reference
Polygalaceae Polygala campestris Whole Plant Di Brazil Johann et al., 2011
Polygalaceae Polygala paniculata Whole Plant E Brazil Johann et al., 2011
Polygalaceae Polygala sabulosa Whole Plant Di, EA Brazil Johann et al., 2011
Polygonaceae Rumex acetosa Leaves, Stems, 
Flowers
E Brazil Johann et al., 2007
Rosaceae Rubus urticaefolius Leaves, Stems, 
Flowers
E, EA Brazil Johann et al., 2007
Smilacaceae Smilax domingensis Leaves, Stems, 
Root, Flowers
E Guatemala Fernández, 2005
Solanaceae Cestrum auriculatum Leaves E Peru Rojas et al., 2003
Valerianaceae Valeriana prionophylla Root E Guatemala Fernández, 2005
Verbenaceae Lippia graveolens Leaves E, He Guatemala Fernández, 2005; Beteta, 
2005
Zingiberaceae Curcuma longa Rhizomes EO Thailand Apisariyakul, 
Vanittanakom, 
Buddhasukh, 1995
Zygophyllaceae Larrea tridentata Leaves E Mexico Verástegui et al.,1996
Ac, acetone; Aq, aqueous; Bu, butanol; Di, dichloromethane; Ch, chloroform; CT, carbon tetrachloride; E, ethanol; EA, ethyl acetate; 
EO, essential oil; Ha, hydroalcoholic; He, hexane; M, methanol; MC, methanol, chloroform, - Not informed by consulted reference.
TABLE I - Medicinal plants with confirmed anti-Sporothrix spp. activity and their taxonomical and anatomical identifications, 
extract types and the country where the study was conducted by the consulted references (cont.)
according to them, the factors that influence the outcome 
of antimicrobial activity of a plant are the technique 
applied, the strain of microorganism used, the origin of the 
plant and the time of its collection, the type of preparation 
and the amount of extract tested, among others.
Agar Diffusion
The anti-Sporothrix spp. activity of medicinal 
plants by agar diffusion test have been described and, 
for most authors, the studies focused on human isolates 
(Apisariyakul et al., 1995; Saikia et al., 2001; Rojas et al., 
2003; Damián-Badillo et al., 2008; Luqman et al., 2008; 
Verástegui et al., 2008; Fatima et al., 2009; Márquez, 
2010; Joshi et al., 2011; Wen et al., 2011), according to 
Table II.
An Agar diffusion test consists of defying a 
microorganism against a biologically active substance 
in a solid medium culture, in which the absense of 
microbial growth is related to the size of the halo 
formed, demonstrating sensitivity of the strain to the 
extract (Pinto, Kaneko, Ohara, 2003). Considered one 
of the simplest and most trusted methods of sensitivity, 
this method is advantageous because of its ease of 
implementation and interpretation of results, as well as 
its use of inexpensive reagents and antibiotics without 
requiring special equipment. However, there is a 
deficiency of mechanization or automation to this method 
(CLSI, 2007). In regards to plant extracts, the difficulties 
with the test are the diffusion of the extract in the culture 
medium and pH of the substances used (Ostrosky et al., 
2008), as well as the presence of contaminants such as 
heavy metals, drugs and other medicinal plants (Veiga 
Jr., Pinto, 2005).
In this methodology, methanol-chloroformic and 
ethyl acetate extracts of Satureja macrostema (Labiateae) 
and Tagetes lucida, Artemisia ludoviciana and Heliopsis 
longipes (Asteraceae) gave growth inhibition of S. 
schenckii in the zone ranging from 1.0 to 1.99 cm (Damián-
Badillo et al., 2008). Better results were observed in 10% 
ethanolic extract of Agave lecheguilla, A. picta, A. scabra 
and A. lophantha (Agavae) between 9.0 and 16 mm at 
concentrations of 4.0 to 6.0 mg mL-1 (Verástegui et al., 
2008). Popularly known as licorice, ethanolic extract from 
the roots of Glycyrrhiza glabra (Fabaceae) also inhibited 
the growth of S. schenckii at 5 mm diameter, as well as 
the active constituent of this plant – glabridin – and the 
ethyl acetate fraction of root with 6 and 7 mm, respectively 
(Fatima et al., 2009).
In traditional Peruvian medicine, a study with 
36 ethanolic extracts of 24 plants from Asteraceae 
family showed the inhibition of S. schenckii to Croton 
ruizianus, Iryanthera lancifolia, Oenothera multicaulis, 
Ophryosporus peruvianus, Senecio culcitioides and 
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TABLE II - Results of agar diffusion test done in plants with antifungal activity against Sporothrix schenckii complex and its 
characteristics of solvent extract tested, botanical family, plant species and fungal strain origin according to reference that 
demonstrated values of inhibition zone





Agavaceae Agave lecheguilla Ethanol Human 10 mm Verastegui et al., 2008
Agavaceae Agave lophantha Ethanol Human 10 mm Verastegui et al., 2008
Agavaceae Agave picta Ethanol Human 16 mm Verastegui et al., 2008
Agavaceae Agave scabra Ethanol Human 9 mm Verastegui et al., 2008
Asteraceae Artemisia ludoviciana Ethanol Unspecified 1to 1.99 cm Damián-Badillo et al., 
2008
Asteraceae Artemisia ludoviciana Methanol Unspecified 1 to 1.99 cm Damián-Badillo et al., 
2008




Ethanol Human 13 mm Rojas et al., 2003
Asteraceae Senecio culcitioides Ethanol Human 15 mm Rojas et al., 2003
Asteraceae Tagetes lucida Methanol Unspecified 1 to 1.99 cm Damián-Badillo et al., 
2008
Asteraceae Tagetes lucida Ethanol Unspecified 1 to 1.99 cm Damián-Badillo et al., 
2008
Campanulaceae Lobelia pyramidalis Essential oil MTCC† 1359 13 mm Joshi et al., 2011
Euphorbiaceae Croton ruizianus Ethanol Human 13 mm Rojas et al., 2003
Fabaceae Glycyrrhiza glabra Ethanol AIIMS◊ 5 mm Fatima et al., 2009
Fabaceae Glycyrrhiza glabra Acetyl acetate AIIMS◊ 7 mm Fatima et al., 2009
Hydrophyllaceae Wigandia urens Ethanol Human 13 mm Rojas et al., 2003
Labiateae Satureja macrostema Ethanol Unspecified 1 to 1.99 cm Damián-Badillo et al., 
2008
Labiateae Satureja macrostema Methanol Unspecified 1 to 1.99 cm Damián-Badillo et al., 
2008
Lamiaceae Rosmarinus officinalis Essential oil AIIMS◊ < 5 mm Luqman et al., 2007
Lauraceae Cinnamomum 
zeylanicum
Hexane Unspecified 14 mm Márquez, 2010
Myristicaceae Iryanthera lancifolia Ethanol Human 13 mm Rojas et al., 2003
Myrtaceae Eucalyptus 
camaldulensis
Acetone Unspecified 12 mm Márquez, 2010
Myrtaceae Eucalyptus citriodora Essential oil MTCC† 1359 6.67 to 27 mm Akhtar et al., 2014
Myrtaceae Psidium acutangulum Ethanol IHEM§15503 22 mm Wen et al., 2011
Myrtaceae Psidium guajava Methanol Unspecified 16 mm Márquez, 2010
Myrtaceae Syzygium aromaticum Hexane Unspecified 43 mm Márquez, 2010
Onagraceae Oenothera multicaulis Ethanol Human 15 to 19 mm Rojas et al., 2003
Poaceae Cymbopogon flexuosus Essential oil Human 35 mm Saikia et al., 2001
Poaceae Cymbopogon martini Essential oil Human 19 mm Saikia et al., 2001
Poaceae Cymbopogon 
winterianus
Essential oil Human 12 mm Saikia et al., 2001
Solanaceae Cestrum auriculatum Ethanol Human 25 mm Rojas et al., 2003
Zingiberaceae Curcuma longa Essential oil Human 3 mm Apisariyakul, 1995
*The resuls were described according authors reference and only species plants with results of inhibition zone were considered; 
†Microbial Type Culture Collection and Gene Bank (Chandigarh, India); ◊All India Institute of Medical Sciences (New Delhi, 
India); §Instutute of Hygiene and Epidemiology-Mycology Laboratory (Brussels, Belgium).
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Wigandia urens that promoted halo of growth inhibition 
of 13 to 19 mm and the best anti-Sporothrix spp. activity 
was related to Cestrum auriculatum with halo of 25 
mm, including against strains with no susceptibility to 
amphotericin B and fluconazole, indicating the importance 
of the search for new compounds for resistant isolates 
(Rojas et al., 2003). 
In another similar study, ethanolic extracts of 
Calycophyllum spruceanum (Rubiaceae), Spondia 
mombin (Anacardiaceae) and Thevetia peruviana 
(Apocynaceae) did not show anti-Sporothrix spp. 
activity, but leaves of Psidium acutangulum (Myrtaceae) 
inhibited S. schenckii with an halo of 22 mm and the 
active chemical composition “3’-formil-2’,4’,6’-
trihidroxidihidrochalcone” was individually tested against 
strains resistants to amphotericin B and fluconazole 
by broth microdilution technique and showed MIC of 
32 µg ml-1, being considered promising for therapeutic 
alternatives in sporotrichosis (Wen et al., 2011).
Popularly known as clove, extracts of hexane and 
acetone at 20% of Syzygium aromaticum (Myrtaceae) 
had greater anti-Sporothrix spp. activity with inhibition 
growth of 28 mm to 43 mm in the disc diffusion method 
on agar and the extracts of Cinnamomum zeylanicum 
(Lauraceae), Eucalyptus camaldulensis and Psidium 
guajava (Myrtaceae), popularly known as cinnamom, 
eucalyptus and guava, respectively, that inhibited S. 
schenkii in zones of 10 to 23 mm, but the most of the 
methanolic extracts of these tested plants did not show 
antifungal activity (Márquez, 2010). Still in Myrtaceae 
family, the ointment formulation of Eucalyptus citriodora 
Hook at 2% was more pronounced against S. schenckii 
with zone of growth inhibition of 27 mm, but cream 
formulation with essential oil and the proper essential oil 
of this plant had also fungistatic activity between 6.67 to 
19.67 mm through agar disc diffusion (Akhtar et al., 2014).
In another study, Cymbogon winterianus (Poaceae) 
essential oil constituted a potential antifungal product 
(Pereira et al., 2011). S. schenckii was inhibited in 
the growth zone of 12 mm at dilution of 1/800 for C. 
winterianus, known as citronella, while C. martini and C. 
flexuosus inhibited with 19 mm and 35 mm, respectively, 
at dilution of 1/1600 (Saikia et al., 2001). In the Ocimum 
genus (Lamiaceae), the essential oils of O. sanctum, O. 
canum (O. americanum) and O. gratissimum was conferred 
activity between 8 and 14 mm of diameter (Sinha, Gulati, 
1990). In other botanical species, S. schenckii has been 
inhibited by Lobelia pyramidalis (Campanulaceae), known 
as lobelia, with 13 mm of diameter (Joshi et al., 2011); 
Curcuma longa (Zingiberaceae), known as turmeric, 
with 3 mm (Apisariyakul et al., 1995), and Rosmarinus 
officinalis (Lamiaceae), known as rosemary, with 2.5 mm 
(Luqman et al., 2007). In commercially-available natural 
products from Perlagonium graveolens (Geraniaceae), 
Singh et al. (2012) showed that the compounds of terpineol 
and geranium oil had antifungal activity, while geraniol, 
phenyl ethyl alcohol and citronella acetate had not shown 
satisfactory activity.
In the methodology adapted by Brancato and 
Golding (1953), Beteta (2005) tested aqueous extracts 
and portions extracted with hexane, chloroform and ethyl 
acetate derived from the leaves of Lippia graveolens 
(Verbenaceae) and the flowers of Bourreria huanita 
(Boraginaceae) and showed that the antifungal activity 
was conferred only to L. graveolens whose hexanic 
fraction inhibited the yeast and filamentous phases 
when tested at a concentration of 0.5 mg mL-1, while the 
ethanolic fraction inhibited only the filamentous phase at 
0.25 mg ml-1. 
Ethanolic extracts of seeds of Phasoelus lunatus 
(Fabaceae) and leaves of Cassia grandis (Fabaceae), 
Diphysa robinioides (Fabaceae), Hymenaea courbaril 
(Caesalpiniaceae), Phasoelus vulgaris (Fabaceae), Senna 
occidentalis (Fabaceae) and Vicia faba (Fabaceae) were 
already tested and proved no activity against the yeast 
phase, but the filamentous phase showed sensitivity only 
to extracts of H. courbaril and D. robinioides tested 
at the concentration of 1 mg mL-1 and the MIC value 
of 0.5 mg mL-1 and 1 mg mL-1, respectively (Sánchez, 
2009). 
In another study, yeast and filamentous phases 
of S. schenckii were inhibited by the ethanolic extracts 
from roots of Dorstenia contrajerva (Moraceae) and 
leaves of Hedyosmum mexicanum (Chloranthaceae), 
being the mycelial phase inhibited at MIC of 0.1 mg mL-1 
and 0.05 mg mL-1, respectively, but the yeast phase was 
only inhibited by H. mexicanum at MIC of 0.1 mg mL-1, 
however, the extracts from leaves of Baccharis triversis 
(Asteraceae), Lippia chiapasensis (Verbenaceae) and 
Ocimum micranthum (Lamiaceae) and the roots of 
Petiveria alliaceae (Phytolaccaceae) did not have 
activity against S. schenckii at maximum concentration of 
0.2 mg mL-1 for both fungal phases (Castellanos, 2007). 
According to these authors, the plants that did not show 
satisfactory activity may have active chemical compounds 
in other botanical portions or when tested in higher 
concentrations, which does not rule out the possibility of 
possessing potential antifungal activity.
In ethanolic extracts from twelve plants native to 
Guatemala at the concentration of 1 mg mL-1 using agar 
diffusion adapted by Brancato and Golding (1953), the 
extracts of Hypericum uliginosum (Clusiaseae), Smilax 
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domingensis (Smilacaceae), Salvia lavanduloides 
(Lamiaceae) and Senna alata (Caesalpiniaceae) inhibited 
S. schenckii in the yeast phase, while only the extracts 
of Lippia graveolens (Verbenaceae) and Valeriana 
prionophylla (Valerianaceae) showed activity for both 
phases of this dimorphic fungus. The other tested plants – 
Cornutia pyramidata (Verbenaceae), Quercus crispifolia 
(Fagaceae), Solanum americanum (Solanaceae), Sterculia 
apetala (Malvaceae), Tabebuia rosea (Bignoniaceae) and 
Tithonia diversifolia (Asteraceae) – did not exhibit activity 
against S. schenckii (Fernández, 2005).
According to Fernández (2005), the yeast phase 
would be more susceptible to the extracts for the 
lesser amount of ergosterol present in the membrane 
cell at this phase, leading to a greater susceptibility to 
permeability changes, as well as by the biosynthesis of 
ergosterol inhibition and other steroids by the active 
compounds present in the extracts. Another hypothesis 
of the antifungal mechanism would be the inhibition of 
its triglycerides and phospholipids biosynthesis or the 
inhibition of oxidative and peroxidative enzymatic activity 
that results in accumulation of toxic concentrations of 
hydrogen peroxide and leads to deterioration of subcellular 
organs and cell necrosis. 
Broth Microdilution Method
Plants from different botanical families presented 
anti-Sporothrix spp. activity through tests of broth 
microdilution in standard strains isolated from humans 
and felines (Verástegui et al., 1996; Johann et al., 2007; 
Luqman et al., 2007; Cleff et al., 2008; Fatima et al., 
2009; Johann et al., 2011; Joshi et al., 2011; Stopiglia 
et al., 2011). This method is based on the proportion 
of microbial growth in liquid medium challenged with 
the concentration of the measured substance using a 
96-well microplate (CLSI, 2002; Pinto et al., 2003). 
Among the main advantages cited of this quantitative 
test are savings in space and reagents, generation of 
quantitative results through values of minimum inhibitory 
concentration and the use of pre-fabricated microdilution 
plates (CLSI, 2002). However, the cost of microdilution 
plates is a disadvantage, because the realization of a large 
number of antifungal tests may elevate costs (CLSI, 
2002). Furthermore, Eloff (1998) observed compounds 
precipitation in some plants extracts and interference in 
the analysis by the high concentration of chlorophyll. 
In spite of these factors, this method is still considered 
advantageous for its high sensitivity and reproducibility 
in relation to other techniques (Eloff, 1998). The results 
of plants with anti-Sporothrix spp. activity confirmed by 
broth microdilution technique, as well as their botanical 
information are displayed in Table III.
Lamiaceae family is known with potential antifungal 
for controlling the growth of pathogenic fungi and the 
occurrence of mycosis (Souza et al., 2010). Rosemary oil 
(Rosmarinus officinalis) showed in vitro activity against 
S. schenckii at concentration of 11 mg mL-1 (Luqman et al., 
2007), as well oregano oil (Origanum vulgare), that 
inhibited S. schenckii concentrations between 250 to 
500 μL mL-1 (Cleff et al., 2008; 2010). In S. schenckii and 
S. brasiliensis, Couto et al. (2015) showed the antifungal 
potential of oregano oil, as well as in its major compound 
(γ-terpinene), which caused morphological alterations in 
hyphae and reduced the adhered conidia numbers. 
From the plants used in traditional medicine in 
Brazil, Johann et al. (2011) exhibited that ethanolic and 
ethyl acetate extracts of Rubus urticaefolius (Rosaceae) 
inhibited the fungal growth at the concentration of 
125 μg mL-1, while Rumex acetosa (Polygonaceae) 
demonstrated activity at 1000 μg mL-1. The same activity 
was observed in the essential oil of Lobelia pyramidalis 
(Campanulaceae), which inhibited the fungal growth at 
MIC of 6.25 mg mL-1 (Joshi et al., 2011). Fatima et al. 
(2009) showed greater activity of ethanolic and hexanic 
extracts of Schinus terebinthifolius (Anacardiaceae) at 
15 μg ml-1, as well as the ethanolic extracts at 15% from 
roots of Glycyrriza glabra (Fabaceae) at 1 mg mL-1 and 
glabridin and ethyl acetate fraction at 0.25 μg mL-1. Other 
plants were tested on S. schenckii, such as Piper regnelii 
(Piperaceae), Herissantia crispa (Malvaceae), Baccharis 
dracunculifolia (Asteraceae), Inga dulcis (Leguminosae) 
and Alternanthera brasiliana (Amaranthaceae) and did 
not show antifungal activity (Johann et al., 2007). In the 
Chihuahuan region (encompassing parts of Northern 
Mexico and the Southwestern United States), fungistatic 
activity was observed in the ethanolic extract at 80% of 
the leaves from Baccharis glutinosa (Compositae) and 
Larrea tridentata (Zygophyllaceae) and roots of Agave 
lecheguilla (Agavaceae) at MIC of 12, 16 and 5 mg mL-1, 
respectively (Verástegui et al., 1996).
In the Piperaceae family, Piper abutiloides 
presented MIC value of 125 μg mL-1 when tested in 
form of hydroalcoholic extract at 80%, but hexane, 
dichloromethane, ethyl acetate and aqueous extractions 
did not show antifungal activity at the maximum tested 
concentration of 1000 μg mL-1 (Johann et al., 2009). In 
the extract with antifungal activity, these authors isolated 
the compounds pseudodillapiol, eupomatenoid-6 and 
conocarpan, which provided fungistatic activity at MIC of 
12.5 μg spot-1, 25 μg spot-1 and 50 μg spot-1 respectivelly, 
when individually tested against S. schenckii.
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In the Polygala genus (Polygalaceae family), the 
ethyl acetate and dichloromethane of P. sabulosa had the 
better activity at MIC of 30 μg mL-1 and 250 μg mL-1, 
respectively, and dichloromethanic and ethanolic extracts 
of P. campestris, P. sabulosa and P. paniculata has 
activity between 500 to 1000 μg mL-1, but no activity 
was observed in extracts from P. cyparissias. The authors 
isolated the compounds “prenyloxycoumarin” and 
“1,2,3,4,5,6-hexanehexol” from P. sabulosa and these 
showed activity in the MIC value of 125 μg mL-1 and 
250 μg mL-1, respectively (Johann et al., 2011).
Stopiglia et al. (2011) demonstrated in vitro efficacy 
of plants from the Pterocaulon genus (Asteraceae family) 
against 24 strains of S. schenckii, and the methanolic 
extract at 10% of P. polystachyum, P. lorentzii, P. lanatum, 
P. cordobense and P. balansae had inhibitory and fungicidal 
activity. Of these, the extract of P. polystachyum showed 
greater results with MIC ranged of 156 to 312 μg mL-1 and 
TABLE III - Results of microdilution test of plants species with activy against strains of Sporothrix schenckii complex and their 
different values of minimal inhibitory concentration according to references and solvent extract with action
Botanical Family Plant Species Solvent Extract Origin of Sporothrix spp.
Minimal Inhibitory 
Concentration Reference




Ethanol, Hexane ATCC♦ 22019 15 μg mL-1 Johann et al., 2007
Asteraceae Pterocaulon 
balansae
Methanol Human 625 μg mL-1 Stopiglia et al., 2011
Asteraceae Pterocaulon 
cordobense
Methanol Human 625 μg mL-1 Stopiglia et al., 2011
Asteraceae Pterocaulon lanatum Methanol Human 625 μg mL-1 Stopiglia et al., 2011
Asteraceae Pterocaulon lorentzii Methanol Human 625 μg mL-1 Stopiglia et al., 2011
Asteraceae Pterocaulon 
polystachyum
Methanol Human 156 μg mL-1 Stopiglia et al., 2011
Campanulaceae Lobelia pyramidalis Essential oil MTCC† 1359 6.25 mg mL-1 Joshi et al., 2011
Compositae Baccharis glutinosa Ethanol Human 12 mg mL-1 Verástegui et 
al.,1996 
Fabaceae Glycyrrhiza glabra Ethanol AIIMS◊ 1 mg mL-1 Fatima et al., 2009
Lamiaceae Origanum vulgare Essential oil Human; Feline 250 μL mL-1 Cleff et al., 2008
Lamiaceae Origanum vulgare Essential oil Human; ATCC 1099-
18; ATCC 5110; 
IPEC* 15383; IPEC 
17943
216 to 1735 μg mL-1 Couto et al., 2015
Lamiaceae Rosmarinus 
officinalis
Essential oil AIIMS◊ 11 mg mL-1 Luqman et al., 2007
Piperaceae Piper abutiloides Hydroalcoholic ATCC♦ 20679 125 μg mL-1 Johann et al., 2009
Polygalaceae Polygala campestris Dichloromethane ATCC♦ 20679 500 μg mL-1 Johann et al., 2011
Polygalaceae Polygala paniculata Ethanol ATCC♦ 20679 1000 μg mL-1 Johann et al., 2011
Polygalaceae Polygala sabulosa Acetyl acetate ATCC♦ 20679 30 μg mL-1 Johann et al., 2011
Polygonaceae Rumex acetosa Ethanol ATCC♦ 22019 1000 μg mL-1 Johann et al., 2007
Rosaceae Rubus urticaefolius Acetyl acetate, 
Ethanol
ATCC♦ 22019 125 μg mL-1 Johann et al., 2007
Zygophyllaceae Larrea tridentata Ethanol Human 16 mg mL-1 Verástegui et 
al.,1996
♦American Type Culture Collection (Manassas, VA, USA); †Microbial Type Culture Collection and Gene Bank (Chandigarh, India); 
*Instituto de Pesquisa Clínica Evandro Chagas (Rio de Janeiro, Brazil); ◊All India Institute of Medical Sciences (New Delhi, India).
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MFC varied between 312 to 1250 μg mL-1.
A variation of the broth microdilution technique, 
the Serial Microdilution Method is performed through 
the confirmation of the MIC value by the use of 
p-iodonitrotetrazolium violet (INT) in each well-test as a 
fungal growth indicator, indicated by reduction of the red 
color of INT formazan and evaluated within a period of 
24 to 48 hours of incubation (Eloff, 1998; Masoko, Picard, 
Eloff, 2005). According to Table IV, acetonic, hexanic, 
dichloromethanic and methanolic extracts from leaves 
of six native species of trees in South Africa, belonging 
to the genus Terminalia (Combretaceae family) showed 
high activity in the MIC values of 0.02 to 0.64 mg mL-1 
(Masoko, Picard, Eloff, 2005), as well as extracts from 
24 plants of Combretum genus (Combretaceae) (Masoko, 
Picard, Eloff, 2007).
Suleiman et al. (2009) showed the anti-Sporothrix spp. 
activity of different extracts from leaves of native species 
trees of South Africa: Combretum vendae (Combretaceae), 
Commiphora harveyi (Burseraceae), Khaya anthotheca 
(Meliaceae), Kirkia wilmsii (Kirkiaceae), Loxostylis 
alata (Anacardiaceae), Ochna natalitia (Ochnaceae) and 
Protorhus longifolia (Anacardiaceae). In different extracts 
at 10% of L. alata, acetonic extract of L. alata exhibited 
better antifungal activity in MIC of 0.04 mg mL-1 in 24 
hours and 0.08 mg mL-1 in 48 hours (Suleiman et al., 2009) 
and other fractions of the L. alata had synergistic activity 
against Sporothrix spp. in the MIC of 0.2 to 1.88 mg mL-1 
(Suleiman et al., 2012). These activities can be explained 
by the lupeol compound, which showed anti-Sporothrix 
spp. activity when individually tested at the MIC values of 
57 μg mL-1 (Suleiman et al., 2013). Lupeol isolated from 
leaves and stem barks of Curtisia dentata B. (Cornaceae) 
showed higher activity (12 μg mL-1) when compared with 
betulinic acid, ursolic acid and 2-α-hydroxy ursolic acid 
isolated, that had also activity between 16 to 32 μg mL-1 
(Shai et al., 2008).
In another study, the ethanolic extract of the 
rhizomes of Agapanthus africanus L. (Liliaceae) had 
activity against Sporothrix spp. with MIC value of 250 μg 
mL-1, and the compound saponin was isolated from this 
extract and was responsible for antifungal activity in MIC 
of 15.6 μg mL-1 (Singh et al., 2008).
Bioautographic Assay
Many researchers carry out bioautographic assay 
to detect new or unidentified compounds in plants of 
interest, in order to pursue and deepen the studies in cases 
of confirmed antimicrobial action (Betina, 1973). This 
test is based on assessing the inhibition zone afforded by 
the extract of interest, through the addition of this extract 
in silica gel plates and further immersion in a fungal 
suspension and addition of p-iodonitrotetrazolium violet 
(Rahalison et al., 1993). Among eight plants popularly 
used in traditional Brazilian medicine, Johann et al. 
(2007) measured the MIC values by broth microdilution 
technique only of six plants of different extracts, because 
those were effective against a several number of pathogens 
tested by bioautographic assay and the ethanolic extract 
of leaves from S. terebinthifolius (Anacardiaceae) showed 
better activity against S. schenckii at 15 μg mL-1.
In plants from Polygala genus, five species presented 
activity in the bioautographic assay and were submitted 
to broth microdilution test, demonstrating that ethanolic 
extract of P. paniculata (1000 μg mL-1) and the fractions of 
dichloromethane and ethyl acetate of P. sabulosa (250 μg 
mL-1and 30 μg mL-1, respectively) showed good antifungal 
activity against S. schenckii (Johann et al., 2011).
Agar Cup Method
Brazilian propolis produced by bees that collected 
pollen from Baccharis dracunculifolia (Asteraceae) 
and araucaria (Araucaria spp. – Araucariaceae) showed 
antifungal activity in the 30% ethanolic extract at the 
concentration of 16 to 2.0 mg mL-1 by the agar cup method, 
in which the antifungal activity is measured by inhibition 
zone diameter. The inhibitory action of both plants 
occurred when tested individually and jointly against S. 
schenckii, whose inhibition diameter ranged between 16 
to 24 mm and the lowest concentration tested (2 mg mL-1) 
of B. dracunculifolia was able to inhibit the fungal growth 
up to 19 mm diameter (Salomão et al., 2008).
The small annual herb Cuminim cyminum L. 
(Apiaceae), popularly known as cumin, is the second most 
popular spice in the world, after black pepper, and showed 
activity against S. schenckii in the zone of inhibition of 
18 mm to essential oil, 12 mm to methanol extract and 
0.3 mm to hydroalcoholic extract, but aqueous extract of 
this plant did not show anti-Sporothrix spp. activity when 
the products where tested at concentration of 0.5 mg mL-1 
(Chaudhary, Husain, Ali, 2014).
IN VIVO STUDIES
In vivo studies with aqueous creams containing 20% 
of acetone extracts (2 g of extract in 10 g of cream) from the 
leaves of different species of Combretaceae were evaluated 
in experimental cutaneous sporotrichosis and showed 
wound-healing properties when administered topically 
three times per week in rats Wistar. The preparations 
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TABLE IV - Results of Minimal Inhibitory Concentration (MIC) in the serial microdilution dilution method in different extracts of 
medicinal plants with activity against Sporothrix spp. in the period of 24 hours
Botanical Family Plant Species Solvent Extract Origin of Sporothrix spp.
MIC at 24 
hours* Reference





Unspecified 0.2 to 
1.88 mg mL-1
Suleiman et al., 2012
Protorhus longifolia Dichloromethane Unspecified 0.84 mg mL-1 Suleiman et al., 2009
Burseraceae Commiphora harveyi Acetone Unspecified 0.31 mg mL-1 Suleiman et al., 2009
Combretaceae Combretum acutifolium; 
C. albopunctactum; C. 
apiculatum; C. edwardsii; 
C. hereroense; C. moggi; 
C. nelsonii; C. zeyheri




C. apiculatum; C. 
edwardsii; C. moggi; C. 
molle; C. mossambicense; 
C. petrophilum













C. hereroense; C. 
mossambicense




C. celastroides spp. 
orientale; C. collinum spp. 
suluense; C. woodii
Acetone Equine 0.08 mg mL-1 Masoko, Picard, 
Eloff, 2007
C. caffrum Methanol Equine 0.32 mg mL-1 Masoko, Picard, 
Eloff, 2007
C. celastroides spp. 
celastroides
Methanol Equine 0.16 mg mL-1 Masoko, Picard, 
Eloff, 2007




Equine 0.16 mg mL-1 Masoko, Picard, 
Eloff, 2007
Combretum erythrophyllum Hexane Equine 0.32 mg mL-1 Masoko, Picard, 
Eloff, 2007
Combretum imberbe Dichloromethane Equine 0.32 mg mL-1 Masoko, Picard, 
Eloff, 2007
Combretum padoides Acetone Equine 0.32 mg mL-1 Masoko, Picard, 
Eloff, 2007
Combretum vendae Hexane Unspecified 0.13 mg mL-1 Suleiman et al., 2009
Terminalia brachystemma; 
T. mollis
Dichloromethane Equine 0.02 mg mL-1 Masoko, Picard, 
Eloff, 2005
Terminalia gazensis; T. 
prunioides; T. sambesiaca




Terminalia prunioides Hexane Equine 0.04 mg mL-1 Masoko, Picard, 
Eloff, 2005
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Botanical Family Plant Species Solvent Extract Origin of Sporothrix spp.
MIC at 24 
hours* Reference
Combretaceae Terminalia sericea Methanol Equine 0.02 mg mL-1 Masoko, Picard, 
Eloff, 2005
Kirkiaceae Kirkia wilmsii Acetone Unspecified 0.26 mg mL-1 Suleiman et al., 2009
Meliaceae Khaya anthotheca Acetone Unspecified 0.11 mg mL-1 Suleiman et al., 2009
Ochnaceae Ochna natalitia Hexane Unspecified 0.08 mg mL-1 Suleiman et al., 2009
* The extrats types of considered plants were those with minimum values of inhibitory concentration at 24 hours.
TABLE IV - Results of Minimal Inhibitory Concentration (MIC) in the serial microdilution dilution method in different extracts of 
medicinal plants with activity against Sporothrix spp. in the period of 24 hours (cont.)
of leaves from Combretum imberbe, C. nelsonii, C. 
albopunctatum and Terminalia sericea (Combretaceae) 
have produced reversal of lesions in 15 days, confirming 
in vivo antifungal activity. Irritating and damaging effects 
from the same plants on skin wounds were not observed, 
indicating the absence of adverse effects on healthy skin of 
the tested animals (Masoko et al., 2010a; Masoko, Picard, 
Eloff, 2010b).
The promising use of  medicinal  plants  in 
sporotrichosis encourages scientific researchers to find a 
new antifungal product. However, there are few studies 
proving the anti-Sporothrix spp. activity of medicinal 
plants. More studies about safe concentrations of their 
use must be performed because these plants can present 
chemical elements with capacity to cause toxic effects 
(Veiga Jr., Pinto, 2005; Leal et al., 2013). More studies are 
needed to determine medicinal plants´ safe use with little 
or no adverse effects in the patient. 
CONCLUSION
In vitro studies suggest plants as sources of new 
promising molecules in the control and treatment of 
sporotrichosis, especially species belonging to the 
families Combretaceae, Asteraceae and Lamiaceae. 
Due to various protocols and methodologies used in the 
studies, as well as to the different tested concentrations, 
we emphasize the difficulty in comparing the fungistatic 
and fungicidal results of plant extracts and it is not 
possible to attribute the plants with better activity. 
Furthermore, the lack of in vivo studies of plants was 
noticed, which reveals the need for deeper studies 
focussed on the action mechanism of the plants, as 
well as their toxicity, side effects and possibility of 
drug interactions in order to understand the safe use of 
medicinal plants for the treatment of sporotrichosis.
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